Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of 5-methyltetrahydrofolate Supplementation on Serum Folate and Homocysteine Level and PPARα and TNFα Gene Expression in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: a Double-blind, Parallel Randomized Controlled Trial Study

NCT07740109 is registered in ClinicalTrials.gov with Tabriz University of Medical Sciences as lead sponsor.

NCT NCT07740109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07740109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of 5-methyltetrahydrofolate Supplementation on Serum Folate and Homocysteine Level and PPARα and TNFα Gene Expression in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: a Double-blind, Parallel Randomized Controlled Trial Study
Lead sponsor
Tabriz University of Medical Sciences
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
August 30, 2027
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

masld, masld - metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction-associated steatotic liver disease, nafld, nafld (non-alcoholic fatty liver disease), nafld (nonalcoholic fatty liver disease), nafld - non-alcoholic fatty liver disease, nafld - nonalcoholic fatty liver disease, nonalcoholic fatty liver disease, nonalcoholic fatty liver disease (nafld)